Jeffrey Martini's most recent trade in Palvella Therapeutics Inc. was a trade of 123,559 Non-Qualified Stock Option (right to buy) done . Disclosure was reported to the exchange on Feb. 5, 2025.
Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
---|---|---|---|---|---|---|---|---|---|---|
Palvella Therapeutics Inc. | Jeffrey Martini | Chief Scientific Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 05 Feb 2025 | 123,559 | 123,559 | - | - | Non-Qualified Stock Option (right to buy) | |
Palvella Therapeutics Inc. | Jeffrey Martini | Chief Scientific Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 05 Feb 2025 | 5,373 | 5,373 | - | - | Incentive Stock Option (right to buy) | |
Palvella Therapeutics Inc. | Jeffrey Martini | Chief Scientific Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 13 Dec 2024 | 126,416 | 126,416 | - | - | Stock Option (right to buy) |